7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway (Cancer Chemotherapy and Pharmacology DOI: 10.1007/s00280-007-0667-5)